Compare PLCE & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLCE | SXTC |
|---|---|---|
| Founded | 1969 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.3M | 177.7M |
| IPO Year | 1997 | 2019 |
| Metric | PLCE | SXTC |
|---|---|---|
| Price | $4.17 | $1.74 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 783.8K | 70.2K |
| Earning Date | 12-16-2025 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,288,160,000.00 | $1,537,987.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.66 | $0.95 |
| 52 Week High | $11.99 | $7.84 |
| Indicator | PLCE | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 28.98 | 66.05 |
| Support Level | $3.91 | $1.52 |
| Resistance Level | $4.12 | $1.61 |
| Average True Range (ATR) | 0.39 | 0.11 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 7.64 | 88.26 |
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.